Abstract The mucin2 (MUC2) mucus barrier acts as the first barrier that prevents direct
contact between intestinal bacteria and colonic epithelial cells. Bacterial factors related to …

In recent years, studies investigating the role of the gut microbiota in health and diseases
have increased enormously–making it essential to deepen and question the research …

Intestinal microbiota dysbiosis is an established characteristic of ulcerative colitis (UC).
Regulating the gut microbiota is an attractive alternative UC treatment strategy, considering …

Background Despite the great success, the therapeutic benefits of immune checkpoint
inhibitors (ICIs) in cancer immunotherapy are limited by either various resistance …

Objective While fecal microbiota transplantation is demonstrated to improve symptoms of
autism spectrum disorder (ASD), it remains unclear whether additional treatment courses …

Background More than 95% of human diseases may be related to the disturbance of gut
microbes. As a treatment method that extensively regulates the gut microbes, fecal …

The use of polysaccharides in preparation of microbially triggered colon-targeted delivery
system has been explored extensively to deliver drugs at the colonic site. This type of …

Hesperetin, a flavonoid from citrus fruits, possess various pharmacological properties,
including anti-inflammatory, anti-oxidative, anti-tumor potentials. However, the role and its …

Abstract Aims Electroacupuncture (EA) at ST36 has been verified to ameliorate experimental
acute colitis. However, the effect of EA on chronic colitis and its mechanism has not yet been …

Intestinal inflammation and microbial dysbiosis are found simultaneously in patients with
fluorosis. However, whether the inflammation derived from fluoride exposure only or …